PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11908189

Cervical pregnancy: two case reports.

Stephen Rosenman·Gary Kleinman
View original source ↗Export metadata ↓

Abstract

REASON FOR STUDY: To determine if there is a safe and effective treatment for cervical pregnancy. MAIN FINDINGS: There is no study presently which shows whether the medical vs surgical vs medical and surgical treatment combined for cervical pregnancy is more efficient. Continued studies are necessary to validate any treatment and confirm which would increase survival with fewer complications. PRINCIPAL CONCLUSION: There is no definitive treatment for cervical ectopic pregnancies. The risk and benefits of each treatment must be entertained before a decision is made on either medical or surgical treatment.

Explore related subjects

Abortifacient Agents, NonsteroidalAdultCervix UteriFemaleHumansMethotrexateMisoprostolPregnancyPregnancy, EctopicCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Stephen Rosenman, Gary Kleinman. 2002. Cervical pregnancy: two case reports.. https://pubmed.ncbi.nlm.nih.gov/11908189/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Interstitial Pregnancy. Ultrasonographic diagnosis and contribution of MRI. A case report].

We report ultrasonographic features of interstitial pregnancy and propose three magnetic resonance imaging criteria for the interstitial pregnancy localization. These criteria may facilitate the differentiation between an interstitial pregnancy and an angular pregnancy. The magnetic resonance imaging may be used whenever ultrasound examination diagnosis of an interstitial pregnancy is equivocal.

Abortifacient Agents, Nonsteroidal↗
PubMed2007

Are two doses of misoprostol after mifepristone for early abortion better than one?

OBJECTIVE: The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. DESIGN: Randomised, placebo controlled trial. SETTING: K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. SAMPLE: A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.

Abortifacient Agents, Nonsteroidal↗